Personal information

No personal information available

Activities

Collapse all

Works (4)

Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition

OncoImmunology
2023-12-31 | Journal article
DOI: 10.1080/2162402X.2022.2156091
Contributors: Julia Koerner; Dennis Horvath; Franziska Oliveri; Jun Li; Michael Basler
Source: check_circle
Crossref

PLGA Particles in Immunotherapy

Pharmaceutics
2023-02-11 | Journal article
DOI: 10.3390/pharmaceutics15020615
Contributors: Dennis Horvath; Michael Basler
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy

Nature Communications
2021-05-18 | Journal article
DOI: 10.1038/s41467-021-23244-3
Contributors: Julia Koerner; Dennis Horvath; Valerie L. Herrmann; Anna MacKerracher; Bruno Gander; Hideo Yagita; Jacques Rohayem; Marcus Groettrup
Source: check_circle
Crossref

Harnessing Dendritic Cells for Poly (D,L-lactide-<i>co</i>-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy.

Frontiers in immunology
2019-04-05 | Journal article
DOI: 10.3389/fimmu.2019.00707
PMID: 31024545
PMC: PMC6460768
Source: Self-asserted source
Dennis Horvath
How many people are using ORCID?